Evidence map›Paper›PMID 29788038›Full record

ArticleBrain : a journal of neurology2018

Testing a longitudinal compensation model in premanifest Huntington's disease.

Sarah Gregory, Jeffrey D Long, Stefan Klöppel, Adeel Razi, Elisa Scheller, Lora Minkova, Eileanoir B Johnson, Alexandra Durr, Raymund A C Roos, Blair R Leavitt and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 8 countries.

Sarah GregoryHuntington's disease Research Centre, UCL Institute of Neurology, University College London, London, UK.
Jeffrey D LongDepartment of Psychiatry, Carver College of Medicine, University of Iowa, Iowa, City, IA, USA.
Stefan KlöppelUniversity Hospital for Old Age Psychiatry, Murtenstrasse 21, 3010 Bern, Switzerland.
Adeel RaziWellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.
Elisa SchellerDepartment of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.
Lora MinkovaDepartment of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.
Eileanoir B JohnsonHuntington's disease Research Centre, UCL Institute of Neurology, University College London, London, UK.
Alexandra DurrICM - Institut du Cerveau et de la Moelle Epinière, INSERM U1127, CNRS UMR7225, Sorbonne Universités - UPMC Université Paris VI UMR_S1127and APHP, Genetic department, Pitié-Salpêtrière University Hospital, Paris, France.
Raymund A C RoosLeiden University Medical Center, Department of Neurology, Leiden, The Netherlands.
Blair R LeavittCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Canada.
James A MillsDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
Julie C StoutSchool of Psychological Sciences and Institute of Clinical and Cognitive Neuroscience, Monash University, Melbourne, Australia.
Rachael I ScahillHuntington's disease Research Centre, UCL Institute of Neurology, University College London, London, UK.
Sarah J TabriziHuntington's disease Research Centre, UCL Institute of Neurology, University College London, London, UK.
Geraint ReesWellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.
Track-On investigators
Huntington's Disease Association · GBLeiden University Medical Center · NLUniversity of Freiburg · DEUniversity of Iowa · USCentre National de la Recherche Scientifique · FRUniversity of British Columbia · CAWellcome Centre for Human Neuroimaging · GBMonash University · AUNED University of Engineering and Technology · PK

Funding

Department of HealthMedical Research Council MR/K023268/1Medical Research Council MR/L012936/1Medical Research Council MR/L02053X/1Wellcome TrustWellcome Trust 200181/Z/15/Z
6 · The paper itself

Abstract

The initial stages of neurodegeneration are commonly marked by normal levels of cognitive and motor performance despite the presence of structural brain pathology. Compensation is widely assumed to account for this preserved behaviour, but despite the apparent simplicity of such a concept, it has proven incredibly difficult to demonstrate such a phenomenon and distinguish it from disease-related pathology. Recently, we developed a model of compensation whereby brain activation, behaviour and pathology, components key to understanding compensation, have specific longitudinal trajectories over three phases of progression. Here, we empirically validate our explicit mathematical model by testing for the presence of compensation over time in neurodegeneration. Huntington's disease is an ideal model for examining longitudinal compensation in neurodegeneration as it is both monogenic and fully penetrant, so disease progression and potential compensation can be monitored many years prior to diagnosis. We defined our conditions for compensation as non-linear longitudinal trajectories of brain activity and performance in the presence of linear neuronal degeneration and applied our model of compensation to a large longitudinal cohort of premanifest and early-stage Huntington's disease patients from the multisite Track-On HD study. Focusing on cognitive and motor networks, we integrated progressive volume loss, task and resting state functional MRI and cognitive and motor behaviour across three sequential phases of neurodegenerative disease progression, adjusted for genetic disease load. Multivariate linear mixed models were fitted and trajectories for each variable tested. Our conceptualization of compensation was partially realized across certain motor and cognitive networks at differing levels. We found several significant network trends that were more complex than that hypothesized in our model. These trends suggest changes to our theoretical model where the network effects are delayed relative to performance effects. There was evidence of compensation primarily in the prefrontal component of the cognitive network, with increased effective connectivity between the left and right dorsolateral prefrontal cortex. Having developed an operational model for the explicit testing of longitudinal compensation in neurodegeneration, it appears that general patterns of our framework are consistent with the empirical data. With the proposed modifications, our operational model of compensation can be used to test for both cross-sectional and longitudinal compensation in neurodegenerative disease with similar patterns to Huntington's disease.

Indexed as

AdultBrainBrain MappingCognitionCohort StudiesCross-Sectional StudiesDisease ProgressionFemaleHumansHuntington DiseaseImage Processing, Computer-AssistedLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedModels, Theoretical

Identifiers

PMID29788038
PMCPMC6022638
OpenAlexW2803113191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.